Factors affecting calcium oxalate dihydrate fragmented calculi regrowth

被引：16

作者：

Costa-Bauzá A. ^{[1
]}

Perelló J. ^{[1
]}

Isern B. ^{[1
]}

Sanchis P. ^{[1
]}

Grases F. ^{[1
]}

机构：

[1] Laboratory of Renal Lithiasis Research, University Institute of Health Sciences Research (IUNICS), University of Balearic Islands

来源：

BMC Urology | / 6卷 / 1期

关键词：

Calcium Oxalate; Extracorporeal Shock Wave Lithotripsy; Renal Calculus; Calcium Oxalate Monohydrate; Calcium Oxalate Dihydrate;

D O I：

10.1186/1471-2490-6-16

中图分类号：

学科分类号：

摘要：

Background: The use of extracorporeal shock wave lithotripsy (ESWL) to treat calcium oxalate dihydrate (COD) renal calculi gives excellent fragmentation results. However, the retention of post-ESWL fragments within the kidney remains an important health problem. This study examined the effect of various urinary conditions and crystallization inhibitors on the regrowth of spontaneously-passed post-ESWL COD calculi fragments. Methods: Post-ESWL COD calculi fragments were incubated in chambers containing synthetic urine varying in pH and calcium concentration: pH = 5.5 normocalciuria (3.75 mM), pH = 5.5 hypercalciuria (6.25 mM), pH = 6.5 normocalciuria (3.75 mM) or pH = 6.5 hypercalciuria (6.25 mM). Fragment growth was evaluated by measuring increases in weight. Fragment growth was standardized by calculating the relative mass increase. Results: Calcium oxalate monohydrate (COM) crystals formed on COD renal calculi fragments under all conditions. Under pH = 5.5 normocalciuria conditions, only COM crystals formed (growth rate = 0.22 ± 0.04 μg/mg·h). Under pH = 5.5 hypercalciuria and under pH = 6.5 normocalciuria conditions, COM crystals and a small number of new COD crystals formed (growth rate = 0.32 ± 0.03 μg/mg·h and 0.35 ± 0.05 μg/mg·h, respectively). Under pH = 6.5 hypercalciuria conditions, large amounts of COD, COM, hydroxyapatite and brushite crystals formed (growth rate = 3.87 ± 0. 34 μg/mg·h). A study of three crystallization inhibitors demonstrated that phytate completely inhibited fragment growth (2.27 μM at pH = 5.5 and 4.55 μM at pH = 6.5, both under hypercalciuria conditions), while 69.0 μM pyrophosphate caused an 87% reduction in mass under pH = 6.5 hypercalciuria conditions. In contrast, 5.29 mM citrate did not inhibit fragment mass increase under pH = 6.5 hypercalciuria conditions. Conclusion: The growth rate of COD calculi fragments under pH = 6.5 hypercalciuria conditions was approximately ten times that observed under the other three conditions. This observation suggests COD calculi residual fragments in the kidneys together with hypercalciuria and high urinary pH values may be a risk factor for stone growth. The study also showed the effectiveness of specific crystallization inhibitors in slowing calculi fragment growth. © 2006 Costa-Bauzá et al; licensee BioMed Central Ltd.

引用

共 22 条

[1]

Krepinsky J., Ingram A.J., Churchill D.N., Metabolic investigation of recurrent nephrolithiasis: Compliance with recommendations, Urology, 56, pp. 915-920, (2000)

[2]

Grases F., Costa-Bauza A., Ramis M., Montesinos V., Conte A., Recurrence of renal lithiasis, Scand J Urol Nephrol, 37, pp. 482-486, (2003)

[3]

Daudon M., Reveillaud R.J., Whewellite and weddellite: Toward a different etiopathogenesis. The significance of morphological typing of calculi, Nephrologie, 5, pp. 195-201, (1984)

[4]

Galan J.A., Conte A., Llobera A., Costa-Bauza A., Grases F., A comparative study between etiological factors of calcium oxalate monohydrate and calcium oxalate dihydrate urolithiasis, Urol Int, 56, pp. 79-85, (1996)

[5]

Asplin J.R., Lingeman J., Kahnoski R., Mardis H., Parks J.H., Coe F.L., Metabolic urinary correlates of calcium oxalate dihydrate in renal stones, J Urol, 159, pp. 664-668, (1998)

[6]

Parent X., Boess G., Brignon P., Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone, Prog Urol, 9, pp. 1051-1056, (1999)

[7]

Grases F., Costa-Bauza A., Ramis M., Monstesinos V., Conte A., Simple classification of renal calculi closely related to their micromorphology and etiology, Clin Chim Acta, 22, pp. 29-36, (2002)

[8]

Cecchetti W., Tasca A., Zattoni F., Villi G., Levorato C.A., Pagano F., Five years experience in experimental laser lithotripsy, Eur Urol, 24, pp. 185-189, (1993)

[9]

Cicerello E., Merlo F., Gambaro G., Maccatrozzo L., Fandella A., Baggio B., Anselmo G., Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients, J Urol, 151, pp. 5-9, (1994)

[10]

Delvecchio F.C., Preminger G.M., Management of residual stones, Urol Clin North Am, 27, pp. 347-354, (2000)

← 1 2 3 →